GGrantIndex
Sort

46,585 grants matching heart failure

Engineered Stem Cells for Cardiac Repair

$776,222
Michael Regnier · University Of Washington · R01 · FY2024 · HL

Molecular Studies of Eukaryotic Gene Regulation

$776,160
Bruce Paterson · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence

$776,054
Steven A Webber · Vanderbilt University Medical Center · U01 · FY2017 · AI

Elucidating Mechanism of Cardiac Fibrosis with Cell Village of Pooled Human iPSCs

$776,035
Joseph C Wu · Stanford University · R01 · FY2024 · HL

Prolonged Normothermic Ex vivo Heart Perfusion (NEVHP)

$776,002
Robert H. Bartlett · University Of Michigan At Ann Arbor · R01 · FY2022 · HL

Development of a Miniaturized, Pediatric Continuous-Flow Total Artificial Heart with a Single Moving Part

$775,981
Kiyotaka Fukamachi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · HL

Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia

$775,931
Hong Chen · Boston Children'S Hospital · R01 · FY2025 · HL

Defining novel mechanisms for regulation of atrial INa and arrhythmias

$775,852
Peter J Mohler · Ohio State University · R01 · FY2017 · HL

Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes

$775,846
George L King · Joslin Diabetes Center · R01 · FY2023 · HL

Elucidating the Role of Adipokines in Mediating and Predicting HF Associated with Obesity

$775,761
Chiadi E Ndumele · Johns Hopkins University · R01 · FY2023 · HL

Myocardial Ischemia and Transfusion (MINT) - DCC

$775,743
Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · HL

Mental Stress and Myocardial Ischemia after MI: Sex Differences, Mechanisms and Prognosis

$775,696
Viola Vaccarino Vaccarino · Emory University · R01 · FY2021 · HL

Mental Stress and Myocardial Ischemia after MI: Sex Differences, Mechanisms and Prognosis

$775,696
Viola Vaccarino Vaccarino · Emory University · R01 · FY2020 · HL

Blood and Urine Biomarkers for Predicting Long-Term Adverse Kidney and Cardiovascular Outcomes after Cardiac Surgery

$775,575
Amanda A Fox · Ut Southwestern Medical Center · R01 · FY2022 · HL

Elucidating Genetic and Environmental Second Hits in Racial and Ethnic Minorities with APOL1 High-Risk Genotypes

$775,497
Girish Nitin Nadkarni · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · DK

ARIC CLINICAL EXAMINATION CENTER

$775,456
Gerardo Heiss · Univ Of North Carolina Chapel Hill · N01 · FY2013 · HL

A Planning Study: Sleep Apnea Intervention for Cardiovascular Disease Reduction

$775,414
Susan S Redline · Brigham And Women'S Hospital · U34 · FY2012 · HL

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury

$775,401
Ali Poyan Mehr · Kaiser Foundation Research Institute · R01 · FY2021 · HL

Skin Sympathetic Nerve Activity and Cardiac Arrhythmias

$775,400
Thomas H Everett · Arrhythmotech, Llc · R42 · FY2016 · DA

Translation of novel and repurposed drugs to address the acute and late effects of mustard exposure

$775,399
Kurt Lu · Northwestern University At Chicago · U01 · FY2020 · AR

Pediatric POTS: does a periaqueductal gray-vagus nerve interface malfunction explain the natural history with its numerous co-morbidities ?

$775,375
Gisela Chelimsky · Virginia Commonwealth University · R01 · FY2025 · HL

Pediatric POTS: does a periaqueductal gray-vagus nerve interface malfunction explain the natural history with its numerous co-morbidities ?

$775,351
Gisela Chelimsky · Virginia Commonwealth University · R01 · FY2024 · HL

Identification and application of regulatory elements for heart regeneration

$775,300
Kenneth D Poss · Duke University · R01 · FY2018 · HL

Optimizing the implementation of personalized risk-prediction models for venous thromboembolism among hospitalized adults

$775,067
Benjamin French · Vanderbilt University Medical Center · R01 · FY2023 · HL

Development of a Universal Bi-ventricular Replacement System for the Failing Heart

$775,023
Joshua P Cysyk · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2023 · HL